BlossomHill Therapeutics, Inc. (BLSM) stock
BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.41−0.18 (-1.23%)
Close on Nov 19, 2026Market cap $36.73MP/E –Yield –
BlossomHill Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BlossomHill Therapeutics's shares outstanding was 3M at Jun 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3M | – |
| Q2 FY2025 | Jun 30, 2025 | 2M | – |
See a number that looks wrong?